Fresenius Medical Care AG
Fresenius Medical Care AG scores highest on Price (82) and lowest on Nitro (36). Its PosiPenta is 50.83 out of 100, around the middle of similar companies.
On the Penta Grid this week, Fresenius Medical Care AG is Grid #3 of 5 in the Healthcare sector in Germany, and Grid #16 of 38 in Germany.
Compared with similar companies in the Healthcare sector in Germany.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Fresenius Medical Care AG | 50.83 | 82 | 50 | 36 | 36 | 51 |
| Fresenius SE & Co. KGaA | 51.89 | 66 | 49 | 51 | 45 | 49 |
| Bayer Aktiengesellschaft | 35.40 | 32 | 47 | 51 | 12 | 34 |
| Siemens Healthineers AG | 46.40 | 42 | 30 | 47 | 49 | 64 |
| Merck KGaA | 57.78 | 40 | 68 | 84 | 53 | 43 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 11.76 |
| P/B ratio | 0.83 |
EEarnings
| Trailing EPS | ₹353.49 |
| Forward EPS | ₹453.15 |
NNitro
| Price | 4156.73 |
| 52-week high | 5061.75 |
| 52-week low | 3680.79 |
| Fall from 52-week high | 17.9% |
TTorque
| Return on equity (ROE) | 8.52% |
| Debt-to-equity | 0.81 |
AAnchor
| Beta (price swings) | 0.81 |
| Market cap | ₹1,10,614 Cr |
| Insider holding | 25.02% |
| Dividend yield | 3.77% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Fresenius Medical Care AG's PosiPenta score?
Fresenius Medical Care AG's PosiPenta is 50.83 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Fresenius Medical Care AG stand on the Penta Grid?
On the Penta Grid this week, Fresenius Medical Care AG is Grid #3 of 5 in the Healthcare sector in Germany, and Grid #16 of 38 in Germany.
Which PosiPenta pillar is strongest for Fresenius Medical Care AG?
Price (valuation), with a score of 82 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Fresenius Medical Care AG?
Nitro (momentum), with a score of 36 out of 100: weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.